Disc battery ingestion in paediatric age

Paolo Quitadamo1, Flora Caruso1, Casimiro Del Monaco2

  • 1Digestive Endoscopy and Gastroenterological Emergency Unit, Santobono-Pausilipon Children's Hospital, Naples, Italy.

Insights

Ingested disc batteries pose a serious health risk to children, with complications linked to esophageal retention, large battery size, young age, and symptoms. Prompt medical evaluation is crucial for managing disc battery ingestion.

Area of Science:

  • Pediatric Gastroenterology
  • Emergency Medicine
  • Toxicology

Background:

  • Disc battery ingestion is a significant concern in pediatric emergency medicine.
  • Timely medical evaluation is essential for managing potential complications.

Purpose of the Study:

  • To analyze clinical data of children with disc battery ingestion.
  • To identify predictors of short- and long-term injuries.
  • To refine treatment guidelines and urgency of intervention.

Main Methods:

  • Retrospective review of pediatric patients admitted for disc battery ingestion (2016-2020).
  • Statistical analysis using odds ratio to determine factors associated with complications.

Main Results:

  • 10.2% of 118 children experienced mild to major complications.
  • Factors predicting poor outcomes included esophageal retention, battery diameter >20mm, age <1 year, and symptomatic presentation.
  • Disc batteries lodged beyond the esophagus were less associated with harm.

Conclusions:

  • Ingested disc batteries are a serious health hazard requiring prompt medical evaluation.
  • Esophageal retention, large diameter, and symptom onset are key predictors of severity.
  • A conservative approach may be suitable for disc batteries located beyond the esophagus.
Abstract

Related Concept Videos

Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
950
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
396
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.4K
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.1K